Behind the Science Q & A with Dr. Elliot Stieglitz

We’d like you to meet Dr. Elliot Stieglitz. Dr. Stieglitz is innovative in discovering new targeted therapies for patients with Juvenile myelomonocytic leukemia also called JMML, a type of blood cancer that affects infants and young children.